Tag:
LY2189265
Latest Headlines
Latest Headlines
GSK's albiglutide flunks head-to-head diabetes PhIII with rival Victoza
GlaxoSmithKline ( $GSK ) has stumbled badly in its first late-stage study of albiglutide, a weekly GLP-1 diabetes drug. Reporting on the top-line results for the first of eight Phase III studies
Lilly's bet on R&D pipeline over mega mergers faces hurdles
Eli Lilly ( $LLY ) has drawn some fresh criticism for the risk in its strategy to rely on its own pipeline to bolster its future product portfolio rather than seek mega mergers like those that some of
